NCT02073175

Development of Dietary Supplements for Mood Symptoms in Postpartum

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Centre for Addiction and Mental Health · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether a dietary supplement (DS) is effective in protecting against sad mood in postpartum.

Detailed description

The specific aim of this open-label study is to assess whether the proposed dietary supplement can reduce the intensity of sadness in women vulnerable to sadness (day-5 postpartum women and women within the first 18 months postpartum with crying spells).

Conditions

• Postpartum Blues
• Healthy

Interventions

Type	Name	Description
DRUG	Motherwell	The interventions involves a dietary supplement called Motherwell, at current stage, to reduce the intensity of sadness in women vulnerable to sadness.

Timeline

• Start date: 2014-02-01
• Primary completion: 2016-04-01
• Completion: 2016-04-01
• First posted: 2014-02-27
• Last updated: 2016-04-13

Locations

1 site across 1 country: Canada